Found: 6
Select item for more details and to access through your institution.
Effects of salmeterol on arterial oxyhemoglobin saturations in patients with cystic fibrosis.
- Published in:
- Pediatric Pulmonology, 2002, v. 34, n. 1, p. 11, doi. 10.1002/ppul.10117
- By:
- Publication type:
- Article
Elexacaftor/Tezacaftor/Ivacaftor in Patients with Cystic Fibrosis Homozygous for the F508del Mutation and Advanced Lung Disease: A 48-Week Observational Study.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 4, p. N.PAG, doi. 10.3390/jcm11041021
- By:
- Publication type:
- Article
Airway Clearance with Expiratory Flow Accelerator Technology: Effectiveness of the "Free Aspire" Device in Patients with Severe COPD.
- Published in:
- Turkish Thoracic Journal / Turk Toraks Dergisi, 2019, v. 20, n. 4, p. 209, doi. 10.5152/TurkThoracJ.2018.18053
- By:
- Publication type:
- Article
Elexacaftor/tezacaftor/ivacaftor as rescue therapy in a patient with the cystic fibrosis genotype F508DEL/G1244E.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Minimum Clinically Important Difference in 30-s Sit-to-Stand Test After Pulmonary Rehabilitation in Subjects With COPD.
- Published in:
- Respiratory Care, 2019, v. 64, n. 10, p. 1261, doi. 10.4187/respcare.06694
- By:
- Publication type:
- Article
Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor Therapy in Three Subjects with the Cystic Fibrosis Genotype Phe508del/Unknown and Advanced Lung Disease.
- Published in:
- Genes, 2021, v. 12, n. 8, p. 1178, doi. 10.3390/genes12081178
- By:
- Publication type:
- Article